Ulf Bergman
Impact in
- Geriatrics and Gerontology top 0.2%
- Pharmaceutical Practices and Patient Outcomes
-
- Antibiotic Use and Resistance
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 18
- Pharmaceutical Economics and Policy 14
-
- Pharmaceutical studies and practices 22
- Co-authors
- Björn Wettermark (23 shared papers)Anders Sundström (4 shared papers)B Westerholm (6 shared papers)Göran Isacsson (15 shared papers)Måns Rosén (1 shared paper)Petra Otterblad Olausson (1 shared paper)Ingemar Persson (1 shared paper)Niklas Hammar (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (29 papers)Pharmacoepidemiology and Drug Safety (18 papers)British Journal of Clinical Pharmacology (6 papers)Journal of Clinical Epidemiology (4 papers)Drug Safety (4 papers)
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Ulf Bergman
174 papers receiving 6.3k citations
Ulf Bergman's Hit Papers
Peers
Comparison fields: 5 of 172
- Geriatrics and Gerontology 913
- Applied Microbiology and Biotechnology 403
- Toxicology 541
- Family Practice 308
- Psychiatry and Mental health 944
Countries citing papers authored by Ulf Bergman
This map shows the geographic impact of Ulf Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Bergman more than expected).
Fields of papers citing papers by Ulf Bergman
This network shows the impact of papers produced by Ulf Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Bergman. The network helps show where Ulf Bergman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulf Bergman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months Hit paper breakdown → | 2006 | 1486 |
| 2 | 2011 | 184 | |
| 3 | 2013 | 156 | |
| 4 | 2007 | 151 | |
| 5 | 1998 | 147 | |
| 6 | 2011 | 139 | |
| 7 | 1988 | 134 | |
| 8 | 2010 | 117 | |
| 9 | 2016 | 115 | |
| 10 | 1981 | 114 | |
| 11 | 1996 | 104 | |
| 12 | 2001 | 104 | |
| 13 | 1994 | 102 | |
| 14 | 2013 | 91 | |
| 15 | 2007 | 89 | |
| 16 | 2014 | 83 | |
| 17 | 1997 | 79 | |
| 18 | 1992 | 77 | |
| 19 | 1999 | 72 | |
| 20 | 1978 | 71 |
About Ulf Bergman
Ulf Bergman is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology, Pharmacology and Psychiatry and Mental health, having authored 178 papers that have together received 6.6k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (33 papers), Pharmaceutical studies and practices (22 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers), Pharmacovigilance and Adverse Drug Reactions (18 papers), Monetary Policy and Economic Impact (17 papers), Antibiotic Use and Resistance (15 papers), Pharmaceutical Economics and Policy (14 papers) and Global Financial Crisis and Policies (11 papers). The work is most often cited by research in Geriatrics and Gerontology (913 citations), Applied Microbiology and Biotechnology (403 citations), Toxicology (541 citations), Family Practice (308 citations) and Psychiatry and Mental health (944 citations). Ulf Bergman has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Björn Wettermark, Anders Sundström, B Westerholm, Göran Isacsson, Måns Rosén, Petra Otterblad Olausson, Ingemar Persson, Niklas Hammar, B.‐E. Wiholm and Michael M. Hutchison. Their work appears in journals such as European Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology, Journal of Clinical Epidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.